Affinivax is a good comp for valuation here - they are a tad further along, have a 24 valent pneumo vax in the clinic w BTD, and a pipeline preclinical including a 30+ valent vax. they got acquired for 2.1B plus an additional 1.2B in milestones last year So PCVX seems fully valued at the current price (and then some)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.